Search

Your search keyword '"Roberta Pica"' showing total 129 results

Search Constraints

Start Over You searched for: Author "Roberta Pica" Remove constraint Author: "Roberta Pica"
129 results on '"Roberta Pica"'

Search Results

1. Antibiotic-Loaded Coatings to Reduce Fracture-Related Infections: Retrospective Case Series of Patients with Increased Infectious Risk

2. Splenic Hematoma as a Rare Complication of Colonoscopy; a Case Report

3. Desmoplasia influenced recurrence of disease and mortality in stage III colorectal cancer within five years after surgery and adjuvant therapy

4. Vitamin D Signaling in Gastro-Rheumatology: From Immuno-Modulation to Potential Clinical Applications

5. Anti-CXCL4 Antibody Reactivity Is Present in Systemic Sclerosis (SSc) and Correlates with the SSc Type I Interferon Signature

6. CD3+CD4+LAP+Foxp3-Regulatory Cells of the Colonic Lamina Propria Limit Disease Extension in Ulcerative Colitis

7. Real-world efficacy and safety of vedolizumab in managing ulcerative colitis versus Crohn’s disease: results from an Italian multicenter study

8. Treatment of Unstable Elbow Injuries with a Hinged Elbow Fixator

9. Replacement of Adalimumab Originator to Adalimumab Biosimilar for a Non-Medical Reason in Patients with Inflammatory Bowel Disease: A Real-life Comparison of Adalimumab Biosimilars Currently Available in Italy

10. Long-term real-life efficacy and safety of infliximab and adalimumab in the treatment of inflammatory bowel diseases outpatients

11. Native/citrullinated LL37-specific T-cells help autoantibody production in Systemic Lupus Erythematosus

12. Comparison of Performances of Adalimumab Biosimilars SB5, APB501, GP2017, and MSB11022 in Treating Patients with Inflammatory Bowel Diseases: A Real-Life, Multicenter, Observational Study

13. I-CARE, a European Prospective Cohort Study Assessing Safety and Effectiveness of Biologics in Inflammatory Bowel Disease

14. Comparison of performances of infliximab biosimilars CT-P13 versus SB2 in the treatment of inflammatory bowel diseases: a real-life multicenter, observational study in Italy

15. Etrolizumab for maintenance therapy in patients with moderately to severely active ulcerative colitis (LAUREL): a randomised, placebo-controlled, double-blind, phase 3 study

16. An Ulcerated Large Colic Lipoma Causing Rectorrhagia Treated With Endoscopic Loop-Assisted Resection

17. Vitamin D Signaling in Gastro-Rheumatology: From Immuno-Modulation to Potential Clinical Applications

18. Paradoxical relationship between proton pump inhibitors and COVID-19: A systematic review and meta-analysis

19. Hepatitis B (HBV) reactivation in patients receiving biologic therapy for chronic inflammatory diseases in clinical practice

20. Candida albicans lung abscess in an illicit drugs user with hepatitis C virus chronic infection

21. SARS-CoV-2: lessons from both the history of medicine and from the biological behavior of other well-known viruses

22. Proprietà privata, sovranità e diritto di escludere: la 'disarmonia produttiva' di Kant

23. Anti-CXCL4 Antibody Reactivity Is Present in Systemic Sclerosis (SSc) and Correlates with the SSc Type I Interferon Signature

24. Enteropathic spondyloarthritis: Results from a large nationwide database analysis

25. P583 Real-life efficacy and safety of Ustekinumab as second- or third-line therapy in Crohn’s disease: results from a large Italian cohort study

26. IL-13 mRNA tissue content identifies two subsets of adult ulcerative colitis patients with different clinical and mucosa-associated microbiota profiles

27. Use of biosimilars in inflammatory bowel disease: a position update of the Italian Group for the Study of Inflammatory Bowel Disease (IG-IBD)

29. Mo1772 LONG-TERM OUTCOMES OF ENDOSCOPIC SUBMUCOSAL DISSECTION STRATEGY FOR LARGE SUPERFICIAL NEOPLASMS IN INFLAMMATORY BOWEL DISEASES

30. CD3+CD4+LAP+Foxp3-Regulatory Cells of the Colonic Lamina Propria Limit Disease Extension in Ulcerative Colitis

31. Prevalence of Colonic Diverticulosis in Patients Affected by Ulcerative Colitis

32. Training Programs on Endoscopic Scoring Systems for Inflammatory Bowel Disease Lead to a Significant Increase in Interobserver Agreement Among Community Gastroenterologists

33. P530 Azathioprine in the maintenance of steroid-free remission in inflammatory bowel disease patients: efficacy and safety in five years of follow-up

34. Regional variations in the use of complementary and alternative medicines (CAM) for inflammatory bowel disease patients in Italy: An IG-IBD study

36. Lamina Propria CD4+LAP+ Regulatory T Cells Are Increased in Active Ulcerative Colitis but Show Increased IL-17 Expression and Reduced Suppressor Activity

37. Mongersen, an oral SMAD7 antisense oligonucleotide, and crohn's disease

38. 2-Week Triple Therapy for Helicobacter pylori Infection is Better Than 1-Week in Clinical Practice: a Large Prospective Single-Center Randomized Study

39. Hematological malignancies in chronic inflammatory bowel diseases: report of five cases and review of the literature

40. Overexpression of Fatty Acid Synthase in Ulcerative Colitis

41. One-week once-daily triple therapy with esomeprazole, levofloxacin and azithromycin compared to a standard therapy for Helicobacter pylori eradication

42. Diffuse febrile dermatosis in a patient with active ulcerative colitis under treatment with steroids and azathioprine: a case of Sweet’s syndrome

43. Tu1938 Endoscopic Training Leads to a Significant Increase in Agreement of Endoscopic Scoring for Inflammatory Bowel Disease (IBD): Final Results of the Igibdendo Educational Project

44. Assessment of Photocatalytic Nano-TiO2 Mortars’ Behavior When Exposed to Simulated Indoor Conditions of Glazed Buildings

45. Azathioprine or methotrexate in the treatment of patients with steroid-dependent or steroid-resistant ulcerative colitis: results of an open-label study on efficacy and tolerability in inducing and maintaining remission

46. P.11.1: Azathioprine in the Maintenance of Steroid-Free Remission in Inflammatory Bowel Disease Patients: Efficacy and Safety in Five Years of Follow-Up

47. Inter-observer agreement in endoscopic scoring systems: preliminary report of an ongoing study from the Italian Group for Inflammatory Bowel Disease (IG-IBD)

48. Extraintestinal manifestations in a large series of Italian inflammatory bowel disease patients

49. Colonic involvement in celiac disease and possible implications of the sigmoid mucosa organ culture in its diagnosis

50. Schwannoma of the rectum: A case report and literature review

Catalog

Books, media, physical & digital resources